sns insider pvt ltd.png
Women’s Health Therapeutics Market Size to Reach USD 61.6 Billion by 2032, Driven by Rising Awareness & Technological Advancements - SNS Insider
October 15, 2024 09:10 ET | SNS Insider pvt ltd
Pune, Oct. 15, 2024 (GLOBE NEWSWIRE) -- According to SNS Insider, The Women’s Health Therapeutics Market was estimated to be USD 43.21 billion in 2023 and is projected to be valued at USD 61.6...
Transparency Market Research
Molecular Oncology Market Size is projected to Reach USD 7.4 billion, Garnering an 11.0% by 2034: Transparency Market Research Inc.
October 11, 2024 08:41 ET | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The global molecular oncology market (분자종양학 시장) was projected to attain US$ 2.3 billion in...
RNAZ White background cropped.jpg
TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology
October 10, 2024 07:00 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Completes Initial Dosing of First Co-hort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology
Breast Cancer Prevention: New Research Shows Most Women Unaware About the Link Between Breast Density and Cancer
October 08, 2024 14:45 ET | D S Simon
HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics' latest survey reveals a major knowledge gap—most women don’t know that dense breast tissue may raise their cancer risk. Recently, OB-GYN...
Breast Cancer Screening Market to Reach $6.7 Billion, Globally, by 2033 at 8.7% CAGR: Allied Market Research
October 07, 2024 13:00 ET | Allied Analytics LLP
Wilmington, Delaware , Oct. 07, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Breast Cancer Screening Market by Test Type (Blood Marker Test, Genetic Test,...
Breast Cancer Awareness Month: The Fight for Accessible Medical Care for Women with Disabilities
October 07, 2024 11:53 ET | D S Simon
HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Accessing healthcare can be a daunting challenge for women with mobility disabilities. From inaccessible patient rooms and exam tables to mammography...
Wake Radiology UNC Rex logo.png
Wake Radiology Celebrates Opening of Expanded, Patient-Centered, State-Of-The-Art Cary Breast Center
October 03, 2024 09:38 ET | Wake Radiology UNC Rex Healthcare
Raleigh, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Wake Radiology’s newly expanded, state-of-the-art Cary Breast Center is open and providing comprehensive breast imaging services in one easily...
Logo.png
Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
October 01, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Wake Radiology
Wake Radiology Launches ‘We See the Difference’ Campaign for Breast Cancer Awareness Month
October 01, 2024 10:00 ET | Wake Radiology UNC Rex Healthcare
Raleigh, N.C., Oct. 01, 2024 (GLOBE NEWSWIRE) -- In recognition of Breast Cancer Awareness Month, Wake Radiology is launching a month-long campaign during October to highlight the importance of...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals’ Lasofoxifene Demonstrates Anti-Estrogen Therapy Increases Immunotherapy Efficacy by Promoting Antitumor Activity of Eosinophils
October 01, 2024 09:00 ET | Sermonix Pharmaceuticals Inc.
The findings were published Sept. 27 in the peer-reviewed journal Science AdvancesLasofoxifene was more effective than fulvestrant in inhibiting estrogen activity in mice models COLUMBUS, Ohio,...